Startups
Biofidelity
https://biofidelity.comGenomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC).
Summary
Industry
Investors
- Octopus Ventures Series B
- Octopus Ventures Series B
- BlueYard Capital Series B
- Longwall Venture Series B
- Agilent Technologies Series B
- Octopus Ventures Series A
- Octopus Ventures Series A
- BlueYard Capital Series A
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable